Nicholas A. Langworthy

Congressman Langworthy Introduces Bipartisan Biosimilars Access & Affordability Act

Position: The release supports legislation that would create a clearer process for Medicare to temporarily delay price negotiation for an original biologic drug when a biosimilar competitor is genuinely moving toward market, with a two-year maximum and protections if that competition does not materialize.

Washington, D.C. —October 2nd… Congressman Nick Langworthy today announced the introduction of the Biosimilars Access and Affordability Act, bipartisan legislation to expand access to lower-cost biosimilar prescription drugs and help bring them to market. The legislation updates Medicare policy to provide a clearer pathway for lower-cost biosimilar medicines that are actively moving toward the market, while protecting Medicare if those anticipated competitors never reach patients. Senator Marsha Blackburn (R-TN) is leading the companion bill in the U.S. Senate. Biosimilars are highly similar versions of biologic medicines that can provide additional treatment options and introduce competition into markets where patients may have limited choices. By encouraging legitimate biosimilar competition, the legislation aims to expand access to treatments and help put downward pressure on drug costs. “Competition is one of the most powerful tools we have to drive innovation and affordability in our healthcare system and biosimilars have helped give millions of patients access to lifesaving drugs at lower costs,” said Congressman Nick Langworthy. “But time is of the essence when dealing with a disease or illness and patients should not have to pay more simply because a lower-cost competitor is on the way, but the rules governing Medicare don't adequately account for it. Our legislation takes a straightforward approach that if a biosimilar is genuinely moving through the FDA process and toward the market, it should have a fair opportunity to compete. At the same time, Medicare should not be left waiting indefinitely if that competition never materializes. This is good for patients, good for research and development, and good for the Medicare system.” Under current law, Medicare can temporarily delay selecting an original biologic drug for price negotiation when a lower-cost biosimilar competitor is expected to enter the market. While the existing policy can allow for a delay of up to two years, it generally operates through separate one-year determinations and has narrow and complicated criteria for qualifying biosimilars. The Biosimilars Access and Affordability Act would maintain the existing two-year maximum while creating a clearer and more predictable process for determining when an approaching biosimilar qualifies for the temporary delay. Specifically, the legislation would: Simplify the existing two-year delay process by establishing a clearer pathway for qualifying biosimilars rather than relying primarily on separate one-year determinations. Recognize concrete evidence that a biosimilar is moving toward the market, including FDA acceptance or approval of an application and required clinical studies that are underway, completed or determined to be unnecessary. Require manufacturers to certify their expected launch information, with legal consequences for knowingly providing false information. Preserve another pathway for strong cases, allowing a manufacturer to seek a delay when it can provide compelling evidence that its biosimilar is highly likely to reach the market. An ongoing patent lawsuit alone would not disqualify a biosimilar. Protect Medicare if anticipated competition never arrives. If a biosimilar is not approved and marketed within the two-year period, the original biologic would enter Medicare's negotiation program, and its manufacturer would owe rebates covering the period during which the negotiated price otherwise would have been in effect. The legislation is also co-led by Reps. Jake Auchincloss (D-MA), John Joyce (R-PA), Linda Sánchez (D-CA), Scott Peters (D-CA), Rudy Yakym (R-IN), Nathaniel Moran (R-TX) as well as original cosponsors, Rep. Mullin (D-CA) and Rep. Panetta (D-CA). Rep. Jake Auchincloss said, “Healthcare premiums are too expensive — going up by more than 10% for employees in Massachusetts. Bringing more biosimilars to market helps lower those premiums for Bay Staters.” "This legislation provides certainty for the future development of biosimilars,” said Rep. Nathaniel Moran. “Biosimilars are vital to our healthcare ecosystem as they provide lower-cost options for patients and produce significant savings for taxpayers. East Texans deserve access to lower drug prices, and I'm glad to co-lead this with Congressman Langworthy.” “As a physician legislator, I know that innovation is the cornerstone of American medicine,” said Congressman John Joyce, M.D. “Maintaining incentives to develop and bring biosimilars to the market helps deliver effective treatments to patients at a lower cost. This legislation is a pro-patient and pro-innovation solution to a harmful consequence of the IRA drug pricing negotiation program.” Congressman Scott Peters said, “Biologics are critical to treating serious illnesses like cancer, autoimmune diseases and genetic disorders, but they are also some of the most expensive drugs on the market. Biosimilars have cut biologic prices by up to 85 percent, yet only a small fraction of name-brand biologics have biosimilars in development. Our bill preserves the biosimilar pathway while incentivizing new development. Red tape should not stand between patients and affordable access to the cutting-edge treatments they need.” The Biosimilars Access and Affordability Act is supported by the Alliance for Aging Research, Arthritis Foundation, Eosinophilic & Rare Disease Cooperative, Community Access National Network, Global Healthy Living Network, International Cancer Advocacy Network, International Pemphigus and Pemphigoid Foundation, Lupus and Allied Diseases Association, Inc., and Roswell Park. “For people facing cancer, access to the right treatment at the right time is incredibly important. Roswell Park is grateful to Congressman Langworthy for his leadership in advancing this smart proposal to expand access to effective cancer therapies while improving affordability for patients and our health care system.” --Candace S. Johnson, PhD, President and CEO, Roswell Park Comprehensive Cancer Center “Biosimilars play an increasingly effective role in the fight against cancer and greatly help with the side effects of treatment. The Biosimilars Access and Affordability Act will increase the number of biosimilars available and reduce costs for patients. It's an important bill which all people fighting cancer and other lethal and chronic diseases should strongly support.” --Marcia K. Horn, JD, President and CEO, ICAN, International Cancer Advocacy Network “Patients living with eye disease deserve to be at the center of every treatment decision, with access to the full range of safe, effective and affordable options available to them and their providers. Biosimilars can play an important role in expanding access and affordability, but lower cost should never come at the expense of effectiveness, patient outcomes, or the ability to choose the treatment that is right for them. Prevent Blindness supports policies that put patients first—expanding access and choice today while preserving the innovation necessary to develop the sight-saving treatments of tomorrow.” --Kira Baldonado, Executive Vice President of Prevent Blindness "For people managing a rare disease, access isn't abstract — it's not just about the medicine that is keeping them stable now, but what is next. Biosimilars are an important part of the treatment landscape, and we should prioritize access to all treatment options." –Sarah Jones, Eosinophilic Rare Disease Coalition Casey McPherson, Executive Director of the Alliance for Patient Access said, “Biosimilars give patients and physicians more affordable options for treating serious and chronic conditions. But unclear rules around Medicare's biosimilar delay provision are discouraging the investment needed to bring these treatments to market. The Biosimilars Access and Affordability Act restores the law's original intent with clear, predictable standards. The Alliance for Patient Access is proud to support this legislation."

Congressman Langworthy Highlights Expanded Dairy Safety Net as 2027 Dairy Margin Coverage Enrollment Opens

Position: The release supports expanding the Dairy Margin Coverage program by increasing the eligible milk production for Tier I coverage from 5 million to 6 million pounds, and encourages eligible dairy producers to enroll for 2027.

Washington, D.C.—October 2nd… Congressman Nick Langworthy today highlighted stronger protections available to dairy farmers through the Dairy Margin Coverage (DMC) program, following the U.S. Department of Agriculture's announcement that enrollment for the 2027 program year will open October 5th. The strengthened DMC program includes a provision Congressman Langworthy championed in his Dairy Farm Resiliency Act (H.R. 294) and successfully advanced into law through H.R. 1, the Working Families Tax Cuts Act. The change increases the amount of milk production eligible for Tier I DMC coverage from 5 million pounds to 6 million pounds, providing greater protection for small and mid-sized dairy operations when milk prices fall, feed costs rise or margins tighten. “Dairy farmers across Western New York and the Southern Tier work incredibly hard to keep their farms operating through markets they cannot control,” said Congressman Nick Langworthy. “I introduced the Dairy Farm Resiliency Act because our dairy farmers deserve a strong and reliable safety net when milk prices and feed costs put pressure on their operations. I am proud that we were able to get this provision across the finish line and into law, giving farmers greater protection when they need it most. I encourage every eligible dairy producer to take advantage of the expanded program and enroll for 2027.” DMC is a voluntary federal risk management program that provides payments when the difference between the national all-milk price and average feed costs falls below a coverage level selected by a participating dairy producer. The program is an important component of the farm safety net for dairy producers across Western New York. USDA announced September 30 that 2027 DMC enrollment will run from October 5 through December 18, 2026, and dairy producers can enroll through their local USDA Farm Service Agency office. USDA also provides a DMC decision tool to help producers evaluate their coverage options. Producers can select coverage levels ranging from $4.00 to $9.50 per hundredweight. The changes secured through H.R. 1 also reauthorized DMC through 2031, established new production-history rules and provided producers who lock in coverage for 2026 through 2031 with a 25 percent premium discount. Issues:Agriculture

Congressman Nick Langworthy Announces $3 Million Federal Investment to Alfred State College for Workforce Development

Position: The release announces federal funding for Alfred State College to modernize skilled-trades education and workforce training, and states support for expanding technology and manufacturing preparation for students.

Washington, DC--September 28th… Congressman Nick Langworthy today announced nearly $3 million in federal funding for Alfred State College to modernize skilled-trades education, expand access to advanced technology and prepare students for in-demand careers across the region. The investments include a $150,000 Appalachian Regional Commission (ARC) award for CNC machining enhancements and a $3 million ($1,797,430 in the first year) Department of Education Title III grant to expand access to skilled trades and next-generation technology. Congressman Langworthy, who has made strengthening the skilled trades industry a top priority during his time in Congress said, “Alfred State has a long history of preparing students for good-paying careers in the skilled trades industry, and these investments will make sure that students have access to the tools and technology they need to compete in the modern workforce. We are working hard at the federal level to revive American manufacturing and strengthen domestic supply chains but if we are going to be successful, we need to make sure the next generation of workers is trained for these jobs. Whether it’s a CNC machine, advanced manufacturing technology or artificial intelligence, our students will be able to gain the skills and experience necessary to hit the ground running.” AWARD OVERVIEWS: ARC AWARD: $150,000 for CNC Machining Enhancements for Trades Education This investment will modernize CNC equipment at Alfred State College, giving approximately 180 students hands-on training with technology used in today’s manufacturing industry. By upgrading training facilities on the Alfred and Wellsville campuses, the Shaping Manufacturing Project will help prepare the next generation of American manufacturing workers with practical skills aligned to in-demand careers in manufacturing, automotive, aerospace, and electronics. The project is expected to help at least 150 students’ complete courses, earn credentials, graduate, and enter the workforce equipped to contribute to America’s advanced manufacturing future. Department of Education Title III: $3 million to increase access to skilled trades and next generation technology Alfred State College has been awarded $1,797,430 for this year, and a total of 3 million over 5 years, will strengthen skilled-trades education by investing in modern equipment, advanced technology, and updating to industry-standard laboratories to prepare students for the next generation of American manufacturing and construction. The initiative will create a smart campus with connected classrooms, upgraded technology infrastructure, AI-integrated curriculum, and opportunities for students to learn directly from industry leaders across the country. By combining hands-on training with expanded tutoring, coaching, financial literacy, and access to tools and technology, the grant will help more students successfully complete their programs and enter the workforce with the skills needed to compete in a rapidly evolving American economy.

Congressman Langworthy Announces Introduction Of Bipartisan Surge to Save Newborns Act

Position: The release announces bipartisan legislation that would provide states with dedicated federal resources to implement newborn screening for serious health conditions on the federal Recommended Uniform Screening Panel.

Clarence, NY—September 25th… Congressman Nick Langworthy today announced the introduction of the bipartisan Surge to Save Newborns Act, bipartisan legislation co-led by Democrat Congresswoman Kim Schrier (WA-8) that would provide states with dedicated federal resources to implement newborn screenings for serious health conditions included on the federal Recommended Uniform Screening Panel (RUSP). Congressman Langworthy made the announcement joined by NFL Hall of Fame Buffalo Bills quarterback Jim Kelly and his wife, Jill, who lost their son, Hunter to Krabbe disease. Image

Congressmen Langworthy and Pocan Introduce Bipartisan COMPACT Act to End Taxpayer-Funded Biomedical Testing on Dogs and Cats

Position: Introduces the COMPACT Act, bipartisan legislation to end federally funded biomedical testing on dogs and cats and modernize federal biomedical research practices.

Washington, D.C. — September 23rd…Congressman Nick Langworthy (NY-23) and Congressman Mark Pocan (WI-02) today announced the introduction of the Companion Animal Protection Against Cruel Testing (COMPACT) Act, the most comprehensive legislation in history to modernize federally funded biomedical research and end inhumane testing practices on dogs and cats. The legislation was announced at a press conference in Washington with the nation’s leading animal wellness organizations and rescue beagles released from Ridglan Farms in Wisconsin, which drew national attention and closure following revelations of widespread abuse. Image

Congressman Langworthy Calls on Speaker Johnson to Bring Senate Passed DHS Bill to House Floor

Position: Congressman Langworthy urges Speaker Johnson to bring a Senate-passed Department of Homeland Security funding bill to the House floor for immediate consideration, arguing that stable DHS funding is necessary to protect the nation and support DHS personnel.

FOR IMMEDIATE RELEASE Congressman Langworthy Calls on Speaker Johnson to Bring Senate Passed DHS Bill to House Floor Washington, D.C. – April 27, 2026…Congressman Nick Langworthy today sent a letter to Speaker Mike Johnson urging the immediate consideration of the Department of Homeland Security funding measure that passed the Senate unanimously last month. Following his arrival to Washington this afternoon, he held a zoom press conference outlining his support for passage. In the letter, Congressman Langworthy stressed that there is no time for delay as the nation continues to face serious homeland security threats and the Department of Homeland Security requires stable funding to carry out its mission of protecting the American people. Watch Congressman Langworthy’s press conference HERE Read Congressman Langworthy's Letter to Speaker Johnson HERE “As put on full display for the American people with the attack surrounding the White House Correspondents’ Dinner this weekend, our country remains at risk,” said Congressman Langworthy. “While we continue to have significant work ahead to fully fund immigration enforcement through the reconciliation process, we should demonstrate clearly that we are committed to delivering solutions at the earliest possible moment.” Congressman Langworthy emphasized that bringing the Senate-passed funding measure to the House floor would send a strong signal that Congress is serious about governing, securing the homeland, and supporting the men and women serving at DHS. “Bringing this Senate-passed funding measure to the floor would send a strong and immediate signal that we are serious about governing and securing the homeland. It would also provide much needed certainty to the men and women of the Department of Homeland Security, who should not be facing yet another potential pay interruption.” Congressman Langworthy urged the Speaker to meet the moment and deliver the kind of leadership Americans deserve, saying “The American people are not interested in the Washington scorecard or Capitol Hill bickering—they want us to lead and get this done. They are looking for action. They want solutions, even if they are partial, and they expect leadership in moments like this.” He noted that while Republicans continue working toward broader, long-term reforms to fully fund immigration enforcement, stabilizing funding for the vast majority of DHS operations should happen immediately. ###

CONGRESSMAN LANGWORTHY VOTES TO RELEASE THE NAMES OF U.S. HOUSE MEMBERS WHO USED THE SEXUAL HARASSMENT SLUSH FUND

Position: Congressman Langworthy voted to publicly release the names of House members who used a taxpayer-funded settlement fund to resolve sexual harassment claims, arguing that transparency and accountability require disclosure rather than concealment by the House Ethics Committee.

CONGRESSMAN LANGWORTHY VOTES TO RELEASE THE NAMES OF U.S. HOUSE MEMBERS WHO USED THE SEXUAL HARASSMENT SLUSH FUND “I don’t care what Party you’re in or what title you hold—I stand with the American people for transparency” Washington, DC—March 5th…Congressman Langworthy today announced that he voted in favor of revealing the names of all members of Congress who have used the taxpayer-funded settlement fund to resolve sexual harassment claims against them. The privileged resolution forced a vote by the full House that would reveal the identities of those who used the slush fund to settle claims for charges made against them by House employees, campaign staff, and lobbyists. Congress has reportedly paid out more than $17 million taxpayer dollars to quietly settle the cases. Congressman Langworthy was one of only 65 members who voted to expose this information to the public. A majority of the 357 members instead voted to refer it to the House Ethics Committee, where the names would continue to be concealed. Congressman Langworthy, who is a member of the House Oversight Committee, also voted in the committee to subpoena the records and make them available to the public. “It’s a disgrace and stain on the institution to have a secret taxpayer-funded slush fund to cover up sexual harassment by members of Congress,” said Congressman Langworthy. “I’m appalled that Congress is shielding the identities of abusers and using precious taxpayer dollars to silence their victims. I don’t care what Party you are in or what title you hold--I stand with the American people for transparency.” Congressman Langworthy has made government accountability and transparency a top priority in Congress. He co-sponsors legislation to ban members from trading individual stocks and passed signature legislation that would create a centralized public database for executive branch financial disclosures. ###

Statement from Congressman Nick Langworthy on the Appointment of Senator Markwayne Mullin to Lead the Department of Homeland Security

Statement from Congressman Nick Langworthy on the Appointment of Senator Markwayne Mullin to Lead the Department of Homeland Security March 5, 2026 “I applaud the President’s announcement that he will appoint Senator Markwayne Mullin to lead the Department of Homeland Security. As a member of the Armed Services Committee where he serves on the subcommittees dealing with emerging threats and readiness, he brings a wealth of experience and management expertise that will allow him to seamlessly take the reins of this critical agency. His pending appointment is welcome news and now it’s time for Democrats to stop blocking funding to the department. There is no more important task than protecting Americans’ safety and keeping this agency shuttered during these volatile times is putting our nation at grave risk.” ### ---

Congressman Langworthy Introduces Dietary Supplement Regulatory Uniformity Act Legislation to Protect Consumer Health and Rein in Burdensome State Overregulation

WASHINGTON, D.C. — February 4, 2026…Congressman Nick Langworthy today introduced the Dietary Supplement Regulatory Uniformity Act, legislation aimed at protecting consumer health while restoring common sense to dietary supplement regulation by reaffirming a single, science-based national standard overseen by the Food and Drug Administration (FDA). Dietary supplements, including vitamins, protein powders, creatine, and other nutrition products, have risen in popularity and are widely used by Americans who rely on clear, accurate information and consistent safety standards. For nearly 30 years, the FDA has regulated these products under federal law to ensure they are safe, properly labeled, and marketed truthfully. In recent years, however, states—led by New York—have moved to impose their own supplement regulations beyond FDA oversight. These state-level mandates have created a confusing patchwork of rules that do nothing to improve public safety but significantly increase costs for small businesses and limit consumer access to lawful products. “This is regulation for regulation’s sake,” said Congressman Nick Langworthy. “New York is notorious for baseless overregulation that burdens small businesses without making anyone safer or improving public health. When states ignore science and override FDA determinations, consumers are misled and local businesses pay the price.” The Dietary Supplement Regulatory Uniformity Act clarifies that FDA sets the national rules for dietary supplements, ensuring consumer health decisions are guided by science—not political headlines or fear-based warnings. The bill prevents states from layering on conflicting requirements, while preserving a process for states to petition FDA if a legitimate, evidence-based local concern exists. By restoring regulatory consistency, the legislation protects consumers from confusing and misleading warnings, reduces unnecessary compliance costs, and allows small retailers, manufacturers, fitness centers, and distributors to operate under one clear, nationwide standard. “At its core, this bill is about protecting consumer health and common sense,” Langworthy added. “If a product is safe under federal law, it shouldn’t be treated as dangerous in New York and lawful just across the border. We can safeguard public health without crushing small businesses and that’s exactly what this legislation does.” Several leading national health organizations have endorsed the legislation, including the Consumer Healthcare Products Association (CHPA), the Natural Products Association (NPA), the American Herbal Products Association (AHPA) and the Council for Responsible Nutrition (CRN). “This legislation secures a single, science-based national standard for dietary supplements, providing the clarity, consistency, and consumer confidence Americans deserve,” said CHPA President and CEO Scott Melville. “For more than 30 years, the nation has relied on a federal framework to regulate dietary supplements, and we thank Congressman Langworthy for his leadership in reinforcing that foundation as policymakers and industry pursue thoughtful modernization. At a time when a patchwork of state-level regulations threatens to create confusion, raise costs, and limit consumer access to safe, beneficial products, this bill maintains a unified national approach while preserving limited flexibility for states when truly necessary.” “Americans benefit when dietary supplements are regulated under one clear, national standard grounded in science,” said Steve Mister, President and CEO of CRN. “This legislation protects consumers from confusing and alarmist state-level restrictions and requirements while ensuring responsible companies can continue to innovate and provide safe, high-quality products nationwide. Strong federal oversight and uniform enforcement are essential to maintaining consumer confidence and ensuring a level playing field for responsible businesses. CRN commends lawmakers for taking action to keep dietary supplement policy grounded in science—not sensationalism.” NPA’s CEO Daniel Fabricant Ph.D. said, “The introduction of Congressman Langworthy’s bill is a decisive and long-overdue answer to state overreach, which has become a defining threat to consumers and the future of the dietary supplement industry. Restoring federal primacy is the only way to ensure a stable, science-based regulatory environment that protects innovation, preserves consumer access, and prevents a costly, unworkable patchwork of state laws. American consumers of dietary supplements deserve clear and consistent national standards that are administered and enforced by the U.S. Food and Drug Administration. We urge industry leaders, retailers, and stakeholders across the supply chain to join us in supporting this essential legislation. We look forward to working with Congressman Langworthy to advance this bill in the 119th Congress.” Graham Rigby, President & CEO of American Herbal Products Association said, “AHPA strongly supports legislation to establish federal preemption, a move essential to protecting the free interstate commerce that defines our nation. An inconsistent patchwork of state regulations would create a highly restrictive environment that would stifle innovation, increase business compliance costs and complexity, and ultimately restrict consumer access. AHPA applauds Congressman Langworthy for introducing the Dietary Supplement Regulatory Uniformity Act, which would appropriately defer to the country’s robust national regulatory framework and help ensure that the millions of dietary supplements sold daily in the U.S. marketplace can reach Americans without needlessly burdensome state-level barriers.” ### Issues:Health

Congressman Langworthy Introduces Legislation to Modernize Federal Workforce Buyout Program

Position: Congressman Langworthy supports modernizing the federal workforce buyout program by removing the 30-year-old $25,000 cap on Voluntary Separation Incentive Payments and tying incentives to employee salary, allowing agencies to offer up to six months' pay to reduce long-term payroll costs.

Washington, D.C. –February 2, 2026…Congressman Langworthy today announced he has introduced the Federal Workforce Early Separation Incentives Act, legislation designed to modernize an outdated federal workforce volunteer buyout program by increasing the financial incentives in a responsible manner. This cost-saving legislation is expected to marked up by the House Oversight Committee, of which Congressman Langworthy is a member, on Wednesday. “Taxpayers deserve a federal government that is efficient, accountable, and appropriately sized,” said Congressman Langworthy. “By ending the 30-year old cap, and instead tying the retirement incentive to earned income, we will make the VSIP more fair and potentially appealing. This legislation brings a common-sense update to a program that has been frozen in time, giving agencies a better option to reduce costs while treating federal employees fairly.” The bill would update the Voluntary Separation Incentive Payment (VSIP) program, first established in the 1990s, which allows federal agencies to offer buyouts to employees who voluntarily leave government service. While VSIP was intended to reduce payroll costs and avoid disruptive reductions-in-force, the program’s $25,000 cap has not been updated in more than 30 years and has lost its effectiveness due to inflation and rising salaries. The Federal Workforce Early Separation Incentives Act removes the outdated statutory cap and allows agencies to offer buyouts of up to six months’ pay. By tying the incentive to an employee’s salary, the program would automatically adjust over time and once again serve as a meaningful option for workforce downsizing. While the updated incentives may result in modest upfront costs, they are expected to produce significant long-term savings by reducing future payroll and retirement obligations. “This bill provides a respectful route to honor federal workers, while being fiscally responsible to shrink the cost of the federal workforce without resorting to layoffs or disruptions.” Congressman Langworthy added. “It gives future administrations another tool to right size government while delivering real savings for taxpayers long term.” The bill would also benefit residents of New York’s 23rd District by reducing the long-term tax burden of the federal bureaucracy and ensuring that federal employees who choose to depart during downsizing efforts are treated fairly. ###